Evaluation of the efficacy and safety of rosuvastatin 5 mg versus pravastatin 40 mg and atorvastatin 10 mg in subjects with type IIa and IIb hypercholesterolaemia
Phase of Trial: Phase IV
Latest Information Update: 15 Jun 2011
At a glance
- Drugs Atorvastatin; Pravastatin; Rosuvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 10 Jun 2017 Biomarkers information updated
- 16 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Mar 2008 New trial record.